4D Molecular Therapeutics (FDMT) Revenue (2020 - 2026)
4D Molecular Therapeutics' (FDMT) quarterly Revenue came in at $3.0 million in Q1 2026, up 21664.29% year-on-year from N/an in Q1 2025, and down 96.42% on a QoQ basis from $85.1 million in Q4 2025.
4D Molecular Therapeutics (FDMT) Revenue (2020 - 2026) Analysis & Trends
4D Molecular Therapeutics (FDMT) has 7 years of Revenue data on file, last reported at $3.0 million in Q1 2026.
- On a quarterly basis, Revenue rose 21664.29% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $88.2 million, a 383560.87% increase from a year earlier, with the FY2025 full-year figure at $85.2 million, up 230194.59% from the prior year.
- Revenue for Q1 2026 stood at $3.0 million, down from $85.1 million in the prior quarter.
- Over the last five years, Revenue for FDMT reached as high as $85.1 million in Q4 2025 and fell as low as -$19000.0 in Q4 2023.
- Historically, Revenue has averaged $6.6 million across 5 years, with a median of $162000.0 in 2022.
- Across the five-year window, Revenue sank 101.52% in 2023 and surged 8508900.0% in 2025, its largest moves.
- Year by year, Revenue stood at $1.2 million in 2022, then slumped by 101.52% to -$19000.0 in 2023, then soared by 105.26% to $1000.0 in 2024, then jumped by 8508900.0% to $85.1 million in 2025, then sank by 96.42% to $3.0 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $3.0 million in Q1 2026, $85.1 million in Q4 2025, and $90000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | 4D Molecular Therapeutics | 691.54 Mn | 300.64 Mn | - | 3.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | 85.09 Mn |
| Sep 30, 2025 | 90,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Dec 31, 2023 | -19,000.00 |
| Sep 30, 2023 | 20.20 Mn |
| Jun 30, 2023 | 239,000.00 |
| Mar 31, 2023 | 298,000.00 |
| Dec 31, 2022 | 1.25 Mn |
| Sep 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 162,000.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 92,000.00 |
| Sep 30, 2021 | 1.37 Mn |
| Jun 30, 2021 | 14.58 Mn |